Justin Ahn, MD
Urology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 13 years
- University of Texas Southwestern Medical School at Dallas, 2013
Offices
2 locations · University of California San Francisco · UCSF Medical Group Business Services
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahn’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A160202 · Current
Licensed to practise in California · since 2019 · expires 2027-01-31 · University of Texas Southwestern Medical Center, Southwestern Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$179,678
Medicare paid this office $179,678 for 281 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 179 | $37,534 | $114 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 36 | $27,359 | $739 |
| Long return visit (40+ min) | 78 | $17,137 | $163 |
| Diagnostic exam of bladder and urethra using an endoscope | 58 | $13,958 | $229 |
| New patient visit (45+ min) | 81 | $11,773 | $145 |
See all 19 services
| Return visit (30+ min) | 179 | $37,534 | $114 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 36 | $27,359 | $739 |
| Long return visit (40+ min) | 78 | $17,137 | $163 |
| Diagnostic exam of bladder and urethra using an endoscope | 58 | $13,958 | $229 |
| New patient visit (45+ min) | 81 | $11,773 | $145 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 18 | $6,275 | $314 |
| New patient visit (60+ min) | 27 | $5,321 | $197 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 13 | $5,162 | $397 |
| Ultrasound scan of pelvic region through rectum | 35 | $5,134 | $147 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 201 | $5,031 | $15 |
| Insertion of device into abdomen with pressure and urine flow rate study | 14 | $2,814 | $201 |
| Crushing, fragmenting, and removal of bladder stones, less than 2.5 cm | 14 | $2,243 | $160 |
| Short return visit (20+ min) | 12 | $988 | $71 |
| Ultrasound measurement of bladder capacity after voiding | 51 | $676 | $12 |
| Electronic assessment of bladder emptying | 59 | $634 | $9 |
| Imaging of urinary tract following injection of a contrast agent | 22 | $583 | $22 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $441 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $410 | $24 |
| Infusion, normal saline solution , 1000 cc | 27 | $57 | None |
Procedures Medicare counted
| Prostate resection | 35 | More than 93% of doctors who do this |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | – | – | 18 | 53 | 58 |
| Diagnostic exam of bladder and urethra using an endoscope | – | – | 28 | 31 | 61 |
| Electronic assessment of bladder emptying | – | – | – | 49 | 69 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | – | – | – | 15 | 37 |
| Crushing of stone of ureter with insertion of stent using an endoscope | – | – | – | – | 20 |
| Insertion of device into abdomen with pressure and urine flow rate study | – | – | – | – | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
281 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 9% · Women 17% · Also on Medicaid 17% · Health risk score 1.38. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 74% · Diabetes 28% · Coronary heart disease 28% · Chronic kidney disease 27% · Cancer 21% · Atrial fibrillation 20% · Depression 16% · Heart failure 14% · COPD 10% · Stroke 9% · Dementia 7%.
The office billed $1,287,800, Medicare allowed $232,670 and paid $179,678; for 1,944 services of 77 kinds; $2,066 of it was for drugs given in the office and $177,612 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 281 | 1,944 | 74 | 1.38 | $1,287,800 | $179,678 |
| 2023 | 155 | 572 | 73 | 1.44 | $514,115 | $77,871 |
| 2022 | 112 | 456 | 72 | 1.28 | $494,506 | $68,936 |
| 2021 | 42 | 63 | 69 | 1.90 | $138,575 | $8,324 |
| 2020 | 18 | 21 | 71 | 2.64 | $120,642 | $4,312 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 71 | $12,231 | $118 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 15 | $10,664 | $711 |
| Long return visit (40+ min) | 39 | $8,465 | $166 |
| Diagnostic exam of bladder and urethra using an endoscope | 30 | $6,936 | $224 |
| New patient visit (45+ min) | 48 | $6,333 | $132 |
| New patient visit (60+ min) | 20 | $3,936 | $197 |
| Ultrasound measurement of bladder capacity after voiding | 48 | $555 | $10 |
| Electronic assessment of bladder emptying | 46 | $511 | $10 |
2022: 9 services
| Return visit (30+ min) | 59 | $9,600 | $113 |
| New patient visit (45+ min) | 52 | $7,264 | $140 |
| Diagnostic exam of bladder and urethra using an endoscope | 27 | $6,877 | $246 |
| Long return visit (40+ min) | 25 | $5,344 | $157 |
| New patient visit (60+ min) | 11 | $2,236 | $203 |
| Ultrasound scan of pelvic region through rectum | 16 | $2,173 | $136 |
| Simple bladder irrigation and/or instillation | 14 | $596 | $43 |
| Imaging of urinary tract following injection of a contrast agent | 18 | $595 | $22 |
| Ultrasound measurement of bladder capacity after voiding | 18 | $176 | $10 |
2021: 2 services
| New patient visit (45+ min) | 13 | $1,750 | $135 |
| Return visit (30+ min) | 11 | $1,493 | $124 |
Medicaid work
$919 in 2024
Medicaid paid $919 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $919 |
| 2024 | 12 | 1 | 12 | $919 |
Drugs they prescribed that Part D paid
$40,931
Pharmacies billed $40,931 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
369 generic and fewer than 11 brand-name prescriptions · $40,931 in drug cost · 63 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 36 | $20,701 | $575 |
| Potassium Citrate Er | 33 | $2,769 | $84 |
| Silodosin | 20 | $2,139 | $107 |
| Tamsulosin | 68 | $1,146 | $17 |
| Estradiol | 19 | $1,065 | $56 |
See all 11 drugs
| Myrbetriq | 36 | $20,701 | $575 |
| Potassium Citrate Er | 33 | $2,769 | $84 |
| Silodosin | 20 | $2,139 | $107 |
| Tamsulosin | 68 | $1,146 | $17 |
| Estradiol | 19 | $1,065 | $56 |
| Methenamine Hippurate | 13 | $627 | $48 |
| Alfuzosin Hcl Er | 25 | $525 | $21 |
| Nitrofurantoin Mono-Macro | 22 | $410 | $19 |
| Finasteride | 37 | $332 | $9 |
| Chlorthalidone | 11 | $117 | $11 |
| Sulfamethoxazole-Trimethoprim | 14 | $39 | $3 |
Year by year
| 2024 | 418 | 132 | None | None | $40,931 |
| 2023 | 192 | 75 | None | None | $23,467 |
| 2022 | 133 | 44 | None | 17% | $12,705 |
| 2021 | 13 | None | 0% (0) | None | $1,804 |
| 2020 | 13 | None | None | 0% | $2,152 |
| 2019 | 39 | 16 | None | 36% | $13,118 |
| 2018 | 46 | 27 | 26% (12) | None | $2,171 |
| 2017 | 49 | 24 | 25% (12) | None | $1,020 |
| 2016 | 83 | 38 | 29% (24) | None | $1,541 |
| 2015 | 51 | 36 | 45% (23) | None | $862 |
| 2014 | 53 | 27 | 40% (21) | None | $3,906 |
| 2013 | 28 | 16 | 46% (13) | None | $1,215 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Myrbetriq | 23 | $15,055 | $655 |
| Tolterodine Tartrate Er | 15 | $3,070 | $205 |
| Estradiol | 14 | $1,239 | $89 |
| Finasteride | 36 | $911 | $25 |
| Tamsulosin | 22 | $522 | $24 |
2022: 3 drugs
| Myrbetriq | 11 | $5,483 | $498 |
| Potassium Citrate Er | 11 | $1,221 | $111 |
| Oxybutynin Chloride | 13 | $121 | $9 |
2019: 1 drug
| Elmiron | 11 | $9,748 | $886 |
2016: 3 drugs
| Tamsulosin | 20 | $462 | $23 |
| Oxybutynin Chloride | 13 | $169 | $13 |
| Oxycodone | 14 | $72 | $5 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 12 | $80 | $7 |
2014: 1 drug
| Oxycodone | 15 | $257 | $17 |
Money from drug and device companies
$1,138 in 2025
| 2025 | 3 | 19 | None | $1,138 |
| 2024 | 4 | 12 | None | $884 |
| 2023 | 3 | 6 | $500 | $961 |
| 2022 | 4 | 13 | $300 | $1,500 |
| 2021 | 1 | 6 | None | $547 |
| 2020 | 1 | 2 | None | $113 |
| 2019 | 2 | 2 | None | $236 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Bph | $628 | 14 payments
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $354 | 3 payments
|
| Cook Medical | Litho 150 | $157 | 2 payments
|
See all 19 published payments
| Boston Scientific | Meals · 2025-08-23 | General - Kidney Stone Disease | $4 |
| Boston Scientific | Meals · 2025-08-23 | Moses | $25 |
| Boston Scientific | Meals · 2025-08-23 | Moses | $15 |
| Boston Scientific | Meals · 2025-08-22 | General - Kidney Stone Disease | $2 |
| Boston Scientific | Meals · 2025-08-22 | Lumenis Pulse 120h | $109 |
| C. R. Bard Inc. & Subsidiaries | Meals · 2025-06-21 | Bard Urinary Drainage Bag | $122 |
| C. R. Bard Inc. & Subsidiaries | Meals · 2025-06-01 | Bard Urinary Drainage Bag | $89 |
| Cook Medical | Meals · 2025-04-27 | Litho 150 | $42 |
| C. R. Bard Inc. & Subsidiaries | Meals · 2025-04-27 | Bard Urinary Drainage Bag | $143 |
| Boston Scientific | Meals · 2025-04-26 | General - Kidney Stone Disease | $34 |
| Boston Scientific | Travel · 2025-03-13 | General - Bph | $117 |
| Boston Scientific | Travel · 2025-03-13 | General - Bph | $168 |
| Boston Scientific | Meals · 2025-03-13 | General - Bph | $9 |
| Cook Medical | Meals · 2025-01-23 | Litho 150 | $114 |
| Boston Scientific | Meals · 2025-01-21 | General - Bph | $15 |
| Boston Scientific | Meals · 2025-01-21 | Moses | $18 |
| Boston Scientific | Meals · 2025-01-21 | General - Therapies | $5 |
| Boston Scientific | Meals · 2025-01-21 | Moses | $7 |
| Boston Scientific | Meals · 2025-01-20 | Moses | $100 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $884
| PROCEPT BioRobotics | Aquabeam System | $291 | 4 payments
|
| Boston Scientific | Lithovue | $279 | 6 payments
|
| Cook Medical | Litho 150 | $162 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $152 | 1 payment
|
2023: $961
| Calyxo | Cvac Aspiration System | $500 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $265 | 2 payments
|
| Boston Scientific | None | $196 | 3 payments
|
2022: $1,500
| Boston Scientific | General - Therapies | $846 | 7 payments
|
| C. R. Bard Inc. & Subsidiaries | None | $435 | 2 payments
|
| FUJIFILM Healthcare Americas | Arietta Precision | $133 | 2 payments
|
| Coloplast | Titan | $87 | 2 payments
|
2021: $547
| Boston Scientific | General Bph | $547 | 6 payments
|
2020: $113
| Boston Scientific | Flexiva | $113 | 2 payments
|
2019: $236
| Intuitive Surgical | Da Vinci Surgical System | $157 | 1 payment
|
| Astellas Pharma US | Xtandi | $78 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1063755148
- Licence
- CA A160202California A160202: Current · expires 2027-01-31
- Trained
- University of Texas Southwestern Medical School at Dallas, 2013 · 13 years ago
- Group
- University of California San Francisco · UCSF Medical Group Business Services
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X)
- Mailing address
- 400 Parnassus Ave, # A610, San Francisco, CA, 94143
- NPI first listed
- 2013-03-27
- NPI last updated
- 2020-01-16
- NPI record certified
- 2020-01-16
This is when the NPI record was last certified, not a medical board exam.